Related Experiment Video
Updated: Jun 27, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Ca(2+)/calmodulin-dependent protein kinase II promotes cell cycle progression by directly activating MEK1 and
Nan Li1, Chunmei Wang1, Yanan Wu1
1Institute of Immunology and National Key Laboratory of Medical Immunology, Second Military Medical University, Shanghai 200433, China.
Abstract:
Cell proliferation is regulated by integration of multiple pathways, such as MAPK, phosphatidylinositol 3'-kinase, protein kinase C, and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) signaling, determining whether the cell proceeds into cell cycle progression. Recently, we have demonstrated that a novel endogenous CaMKII-inhibitory protein, hCaMKIINalpha, suppresses tumor growth by inducing cell cycle arrest via p27 stabilization, accompanied by MEK/ERK deactivation. The data indicate a potential link between Ca(2+)/CaMKII and other signaling pathways, such as MAPK signaling. However, the detailed mechanisms of cross-talks between these important pathways on cell cycle regulation have not been specified. Here we report that CaMKII, in colon adenocarcinoma cells, activates MEK/ERK, which is responsible for the phosphorylation and subsequent proteasomal degradation of p27, thus causing the promotion of the S-G(2)/M transition of cell cycle progression. Importantly, we found that CaMKII can bind to MEK1 and that active CaMKII directly phosphorylates MEK1 in vitro, which could be abrogated by CaMKII inhibitor. Besides, ERK2 can directly interact with and phosphorylate p27. This is the first demonstration that CaMKII interplays with MEK1 and regulates p27 phosphorylation in the cell cycle progression. These findings provide mechanistic evidence for the cross-talk between CaMKII and MAPK signaling, which converges in MEK/ERK activation in the regulation of cell cycle progression.
Insights
Calcium/calmodulin-dependent protein kinase II (CaMKII) activates MEK/ERK signaling, leading to p27 protein degradation and promoting cell cycle progression in colon cancer cells. This reveals a novel cross-talk mechanism between CaMKII and MAPK pathways in cell cycle regulation.
Area of Science:
- Cellular Biology
- Molecular Signaling
- Cancer Research
Background:
- Cell proliferation relies on integrated signaling pathways including MAPK, PI3K, PKC, and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII).
- Previous work identified hCaMKIINalpha as a CaMKII-inhibitory protein that suppresses tumor growth by arresting the cell cycle via p27 stabilization and MEK/ERK deactivation.
- The precise mechanisms of cross-talk between CaMKII and MAPK signaling in cell cycle regulation remain unclear.
Purpose of the Study:
- To elucidate the mechanistic details of the interplay between CaMKII and MAPK signaling pathways in regulating cell cycle progression.
- To investigate the role of CaMKII in activating MEK/ERK signaling and its downstream effects on p27.
- To provide mechanistic evidence for the cross-talk between CaMKII and MAPK signaling in colon adenocarcinoma cells.
Main Methods:
- Investigated CaMKII activation of MEK/ERK signaling in colon adenocarcinoma cells.
- Utilized in vitro assays to examine CaMKII binding to and phosphorylation of MEK1.
- Assessed the interaction and phosphorylation of p27 by ERK2.
Main Results:
- CaMKII activates MEK/ERK signaling, which phosphorylates and degrades p27, promoting cell cycle progression from S to G2/M phase.
- CaMKII directly binds to and phosphorylates MEK1 in vitro, an effect inhibited by CaMKII inhibitors.
- ERK2 directly interacts with and phosphorylates p27.
Conclusions:
- This study demonstrates for the first time that CaMKII interacts with MEK1 and regulates p27 phosphorylation, impacting cell cycle progression.
- Established mechanistic evidence for cross-talk between CaMKII and MAPK signaling pathways.
- Highlights the convergence of CaMKII and MAPK signaling through MEK/ERK activation in controlling cell cycle progression.
Related Concept Videos
MAPK Signaling Cascades
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

